Clinical Trial Update: Autologous Stem Cell Rescue for Primary Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous stem cell rescue for primary amyloidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis

Snippet

Sponsor: Stanford University | Conditions: Amyloidosis, Blood and Marrow Transplant (BMT) | Phase 2 | Status: COMPLETED